Disclose an Invention

Connect with UIRF

Connect with any of our licensing team members to learn more or discuss your ideas.

View Available Technologies

Attend a Class

Learn about intellectual property, licensing, and commercialization at one of our virtual classes.

Unsure where to start?

Our staff are here to help guide UI innovators who want to commercialize new innovations.

 

Subscribe to the UIRF Newsletter

Receive periodic emails from UIRF regarding funding announcements, educational opportunities, events, and more.

Latest Innovations

Speleofilter: Pencil Beam Proton Therapy Configurator

Transdermal Patch for Sustained Drug Delivery

Particle Contamination Elimination in Semiconductor Manufacturing

Double Stranded mRNA Vaccine

News feed

Upcoming deadline for Iowa JPEC Innovation Challenge Fall 2023

Tuesday, October 24, 2023
The Innovation Challenge will bring $225,000 in total funding during the 2023-24 academic year across the University of Iowa's campus. The Challenge is a university-wide competition with the goal to identify, advance and support the most innovative and entrepreneurial projects on campus.

hC Bioscience Moves to Boston's Seaport as Part of its Commitment to Employees and Innovation

Wednesday, July 12, 2023
hC Bioscience, co-founded by UI Faculty Dr. Chrisopher Ahern, has moved and consolidated its team to a new biotech-dedicated facility located in Boston's Seaport. The office, situated at 645 Summer Street, Suite 102, will serve as an important hub for hC Bioscience's continued growth and innovation in the field of tRNA.

Onel team uses LHC technology to develop a device used in radiation oncology

Wednesday, May 31, 2023
As part of his work in high-energy particle physics, Prof. Yasar Onel and his team have invented a scintillator that would be used in an ultra-fast radiation treatment for cancer.

UI engineering faculty members license inventions

Friday, April 7, 2023
Inventions of two University of Iowa College of Engineering faculty members have been licensed for commercial use. They are the latest technology transfer examples in which research emerging from UI laboratories is spun-out to a private company for broader public benefit.

Initial Results From First Patient Dosed With Perspective Therapeutics’ Lead Drug VMT-α-NET Presented at The Treatment of Neuroendocrine Disorders at the 2023 PET/RTRC Annual Workshop Scientific Session

Wednesday, March 29, 2023
Perspective, Therapeutics, Inc., a precision oncology company developing alpha-particle therapies and complementary diagnostic imaging agents based in-part on IP licensed from UIRF, and an innovator in seed brachytherapy powering expanding treatment options for multiple cancers, announced the presentation of extremely encouraging results regarding 212Pb-VMT-α-NET, its lead preclinical candidate for neuroendocrine tumors (NET), currently being used therapeutically in India on a compassionate use basis.

2024 Equalize pitch competition.

Established in 2020, Equalize is a comprehensive program designed to take national action around the disparity of women academic inventors forming university startups. Equalize participants receive education, a field-specific mentor, and access to networks that drive new entrepreneurial connections. If you would like to participate or have any questions, please feel free to reach out to a licensing associate.

47

New Licenses and options granted to UI technologies

FY2023

175

New patent applications

FY2023

72

New invention disclosures

FY2023